Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
February 02, 2009 07:00 ET
|
Human Genome Sciences, Inc.
ROCKVILLE, MD--(Marketwire - February 2, 2009) - Human Genome Sciences,
Inc. (NASDAQ: HGSI) today announced that it has begun delivery of
20,000 doses of its human monoclonal antibody drug...